KR20020049492A - A process for preparing pyridone derivative - Google Patents

A process for preparing pyridone derivative Download PDF

Info

Publication number
KR20020049492A
KR20020049492A KR1020000078674A KR20000078674A KR20020049492A KR 20020049492 A KR20020049492 A KR 20020049492A KR 1020000078674 A KR1020000078674 A KR 1020000078674A KR 20000078674 A KR20000078674 A KR 20000078674A KR 20020049492 A KR20020049492 A KR 20020049492A
Authority
KR
South Korea
Prior art keywords
formula
represented
acid
pyridone derivative
pyridone
Prior art date
Application number
KR1020000078674A
Other languages
Korean (ko)
Other versions
KR100390777B1 (en
Inventor
최일영
정명희
양준연
이효원
Original Assignee
김충섭
한국화학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김충섭, 한국화학연구원 filed Critical 김충섭
Priority to KR10-2000-0078674A priority Critical patent/KR100390777B1/en
Publication of KR20020049492A publication Critical patent/KR20020049492A/en
Application granted granted Critical
Publication of KR100390777B1 publication Critical patent/KR100390777B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385Saturated compounds containing a keto group being part of a ring
    • C07C49/403Saturated compounds containing a keto group being part of a ring of a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

PURPOSE: Provided is a process for preparing pyridone derivative represented by the formula(1) and useful as a therapeutics of Alzheimer's disease(AD). CONSTITUTION: The process for preparing pyridione derivative of the formula(1) comprises the steps of; reacting 1,4-cyclohexanedione monoketal of the formula(2) with secondary amine under acid catalyst; then treating the resultant with propiolamide of the formula(3) to obtain the compound of the formula(1). In the formulae, R1 and R2 represent individually C1-C6 alkyl group or R1 and R2 bind together to form 5-8 membered hetero ring.

Description

피리돈 유도체의 제조방법{A process for preparing pyridone derivative}A process for preparing pyridone derivative

본 발명은 노인성 치매 치료제로 유효한 다음 화학식 1로 표시되는 피리돈 유도체의 제조방법에 관한 것으로서, 더욱 상세하게는 다음 화학식 2로 표시되는 1,4-사이클로헥세인다이온 모노케탈을 2차아민과 산 촉매하에 반응시킨 후에, 프로피올아미드로 처리하는 비교적 간편한 제조방법에 의해 다음 화학식 1로 표시되는 피리돈 유도체를 고수율로 제조하는 방법에 관한 것이다.The present invention relates to a method for preparing a pyridone derivative represented by the following Chemical Formula 1, which is effective as a treatment for senile dementia, and more specifically, a 1,4-cyclohexanedione monoketal represented by the following Chemical Formula 2 with a secondary amine After reacting under an acid catalyst, the present invention relates to a method for producing a pyridone derivative represented by the following general formula (1) in a high yield by a relatively simple production process treated with propiolamide.

상기에서 : R1및 R2는 각각 C1∼C6알킬기이거나, 또는 R1및 R2가 서로 결합하여 5원자 내지 8원자 헤테로 고리를 형성할 수 있다.In the above: R 1 and R 2 are each a C 1 to C 6 alkyl group, or R 1 and R 2 may be bonded to each other to form a 5 to 8 membered hetero ring.

상기 화학식 1로 표시되는 피리돈 유도체는 치매 치료제로서 공지된후퍼진(Huperzine)의 합성을 위한 주요 중간체로 잘 알려져 있다.The pyridone derivative represented by Formula 1 is well known as a major intermediate for the synthesis of Huperzine, which is known as a treatment for dementia.

후퍼진(Huperzine)은 1986년에 중국의 이끼류에서 분리한 천연물로 중국에서는 종기, 해열, 정신분열증 등의 치료를 목적으로 사용하여 왔다. 또한, 후퍼진(Huperzine)은 현재 시판중인 타크린(tacrine), 도네페질(Donepezil; Aricept)과 비교하였을때 독성이 적고 치매환자의 기억력 증진에 좋은 효과를 보여 준다. 현재까지 알려진 바에 의하면, 후퍼진(Huperzine)보다 좋은 치매치료약은 없는 것으로 사료된다. 그러나, 후퍼진(Huperzine)은 천연물로서 천연에서의 함량이 <0.01%이고 자원도 제한되어 있어 대량생산에 많은 제약이 있다. 따라서, 후퍼진(Huperzine) 전합성에 많은 노력이 요구된다.Huperzine is a natural product isolated from Chinese moss in 1986 and has been used in China for the treatment of boils, fever and schizophrenia. In addition, Huperzine is less toxic compared to the currently available tacrine and Donepezil (Aricept), and shows a good effect on improving memory in dementia patients. As far as is known, no dementia medication is better than Huperzine. However, Huperzine is a natural product, which has a content of <0.01% in nature and limited resources, thereby limiting mass production. Therefore, much effort is required for the synthesis of Huperzine.

A. Kozikowski는 상기 화학식 2로 표시되는 1,4-사이클로헥세인다이온 모노에틸렌 케탈을 출발물질로 사용하고, 다음에 나타낸 각각의 제조방법에 의하여 상기 화학식 1로 표시되는 피리돈 유도체를 합성하는 방법을 보고한 바 있다[J. Chem. Soc. 1990, 195].A. Kozikowski uses a 1,4-cyclohexanedione monoethylene ketal represented by Formula 2 as a starting material, and synthesizes a pyridone derivative represented by Formula 1 according to the respective preparation methods shown below. I have reported how to do it [J. Chem. Soc. 1990, 195].

다음에 나타낸 바와 같이 만니히 염기, 피리디늄염 등을 사용하여 아주 낮은수율(9%)로 피리돈 유도체를 합성하는 방법을 보고한 바 있다.As described below, a method of synthesizing a pyridone derivative using a Mannich base, a pyridinium salt, and the like in a very low yield (9%) has been reported.

다음에 나타낸 바와 같이 피롤리딘, α-클로로아크릴아마이드 등을 사용하여 역시 낮은 수율(11%)로 피리돈 유도체를 합성하는 방법을 보고한 바 있다.As shown below, a method of synthesizing pyridone derivatives using pyrrolidin, α-chloroacrylamide and the like in low yield (11%) has also been reported.

다음에 나타낸 바와 같이 음이온화 반응 및 메틸 시스-3-클로로아크릴레이트와 반응시킨 후 암모니아수로 처리하여 22% 수율로 피리돈 유도체를 합성하는 방법을 보고한 바 있다.As shown below, a method of synthesizing a pyridone derivative in 22% yield by treating with anionization reaction and methyl cis-3-chloroacrylate followed by treatment with ammonia water has been reported.

또한, A. Kozikowski는 상기한 제조방법 이외에도 피롤리딘 등과 반응시킨 후에 아크릴아마이드와 반응시켜 이중결합이 없는 피리돈을 얻은 다음, 피리돈의 NH를 보호하고 이중결합 도입 그리고 보호기를 제거하는 여러 단계를 거쳐 최고 45% 수율로 피리돈 유도체를 합성하는 방법을 보고한 바도 있다[J. Org. Chem.4636].In addition to A. Kozikowski, in addition to the above-described preparation method, after reacting with pyrrolidin and the like, acrylamide is obtained to obtain pyridone without a double bond, and then various steps of protecting NH from pyridone, introducing a double bond and removing a protecting group. We have also reported a method for synthesizing pyridone derivatives up to 45% yield [ J. Org. Chem. 4636].

이 방법은 상기한 방법들에 비교하여 수율이 많이 개선된 효과는 있지만, 대량 합성이 어렵고 수율의 변동이 심하며 5 단계 전체수율은 대략 45% 정도이다.This method has the effect of much improved yield compared to the above methods, but the mass synthesis is difficult, the fluctuation of the yield is high, and the overall five-step yield is about 45%.

또다른 방법으로서, 100 ℃ 정도 및 200 기압 정도를 유지하는 고압반응용기에서 메탄올에 용해한 암모니아 가스를 사용하여 피리돈 유도체를 70% 수율로 얻었다. 이 방법의 경우 수율은 비교적 합리적이지만 고압반응으로 인한 위험성을 내포하고 있다.As another method, pyridone derivatives were obtained in 70% yield using ammonia gas dissolved in methanol in a high pressure reaction vessel maintained at about 100 ° C. and about 200 atm. The yield is relatively reasonable for this method, but it poses the risk of high pressure reaction.

이에, 본 발명자들은 보다 공업적으로 유리하고 제조수율도 우수한 상기 화학식 1로 표시되는 피리돈 유도체를 제조하고자 노력하였다. 그 결과, 상기 화학식 2로 표시되는 화합물을 출발물질로 사용하고, 이를 2차아민과 산촉매하에서 반응시킨 후에 프로피올아미드로 처리하는 간편한 제조방법으로 고수율의 피리돈 유도체를 합성함으로써 본 발명을 완성하게 되었다.Thus, the present inventors have tried to produce a pyridone derivative represented by the formula (1) more industrially advantageous and excellent production yield. As a result, the present invention is completed by synthesizing a high yield pyridone derivative using a compound represented by Chemical Formula 2 as a starting material, and reacting it with a secondary amine under an acid catalyst and then treating with propiolamide. Was done.

따라서, 본 발명은 상기 화학식 1로 표시되는 피리돈 유도체를 공업적으로 유리하게 제조하는 방법을 제공하는데 그 목적이 있다.Accordingly, an object of the present invention is to provide a method for industrially advantageously preparing a pyridone derivative represented by Chemical Formula 1.

본 발명은 다음 화학식 2로 표시되는 1,4-사이클로헥세인다이온 모노케탈을 2차아민과 산 촉매하에 반응시킨 후에, 다음 화학식 3으로 프로피올아미드로 처리하여 다음 화학식 1로 표시되는 피리돈 유도체를 제조하는 방법을 그 특징으로 한다.The present invention is the reaction of 1,4-cyclohexanedione monoketal represented by the following formula (2) with a secondary amine and an acid catalyst, and then treated with propiolamide by the following formula (3) to the pyridone represented by the following formula (1) It is characterized by a method for producing a derivative.

상기 화학식에서 : R1및 R2는 각각 C1∼C6알킬기이거나, 또는 R1및 R2가 서로 결합하여 5원자 내지 8원자 헤테로 고리를 형성할 수 있다.In the above formula: R 1 and R 2 are each a C 1 ~ C 6 alkyl group, or R 1 and R 2 may be bonded to each other to form a 5 to 8 membered hetero ring.

이와 같은 본 발명을 더욱 상세히 설명하면 다음과 같다.Referring to the present invention in more detail as follows.

본 발명은 상기 화학식 2로 표시되는 1,4-사이클로헥세인다이온 모노케탈으로부터 상기 화학식 1로 표시되는 피리돈 유도체 합성을 위하여, 피롤리딘과 산 촉매 하에서 반응한 후에 프로피올아미드에 의한 반응을 수행하는 2단계 공정으로 구성된다. 상기한 본 발명의 2단계 공정은 중간체의 분리공정 없이 일용기반응(one-pot reaction)으로 수행할 수도 있다.The present invention for the synthesis of pyridone derivatives represented by the formula (1) from the 1,4-cyclohexanedione monoketal represented by the formula (2), the reaction with pyrrolidin and an acid catalyst and then reaction with propiolamide It consists of a two-step process to carry out. The two-step process of the present invention described above may be carried out in a one-pot reaction without an intermediate separation process.

상기에서 : R1및 R2는 각각 C1∼C6알킬기이거나, 또는 R1및 R2가 서로 결합하여 5원자 내지 8원자 헤테로 고리를 형성할 수 있다.In the above: R 1 and R 2 are each a C 1 to C 6 alkyl group, or R 1 and R 2 may be bonded to each other to form a 5 to 8 membered hetero ring.

상기 화학식 2로 표시되는 1,4-사이클로헥세인다이온 모노케탈을 2차아민 및 산촉매 하에서의 반응은 용매환류 조건하에서의 가열반응에 의해 수행되며, 반응도중에 계속적으로 물이 생성되므로 딘-스탁(Dean-Stark) 물 분리기를 설치하여 더 이상의 물이 생성되지 않을 때까지 반응을 수행한다. 상기 반응에 사용되는 2차아민으로는 피롤리딘, 모르폴린, 피페리딘 등의 이나민류가 사용될 수 있고, 산촉매로는p-톨루엔술폰산, 캄파술폰산, 피리디니움 파라톨루엔술폰산, 황산 등이 사용될 수 있다. 그리고, 반응용매로는 벤젠, 톨루엔, 자일렌 등의 방향족탄화수소류를 사용한다.The reaction of the 1,4-cyclohexanedione monoketal represented by Chemical Formula 2 under the secondary amine and the acid catalyst is carried out by heating under solvent reflux conditions, and water is continuously produced during the reaction, so Dean-Stark (Dean Stark) Install a water separator and carry out the reaction until no more water is produced. Inamines such as pyrrolidine, morpholine, and piperidine may be used as secondary amines used in the reaction, and acid catalysts include p -toluenesulfonic acid, campasulfonic acid, pyridinium paratoluenesulfonic acid, sulfuric acid, and the like. Can be used. As the reaction solvent, aromatic hydrocarbons such as benzene, toluene and xylene are used.

다음으로는 상기 반응액을 진공 증류시켜 용매를 제거한 다음, 프로피올 아마이드를 가하고 용매환류 조건하에서의 다시 가열반응을 수행한다. 이때, 반응용매로는 다이옥산, 테트라하이드로퓨란 등의 고리형 에테르 계열의 용매를 사용한다.Next, the reaction solution is vacuum distilled to remove the solvent, and then propionol amide is added and heating is performed again under solvent reflux conditions. In this case, a cyclic ether solvent such as dioxane or tetrahydrofuran is used as the reaction solvent.

상기 반응이 완결되면 용매를 감압하에 증류시키고 크로마토그래피 등의 통상의 분리 정제 방법을 수행하여 본 발명이 목적하는 상기 화학식 1로 표시되는 피리돈 유도체를 수득한다.When the reaction is completed, the solvent is distilled under reduced pressure and a conventional separation and purification method such as chromatography is performed to obtain a pyridone derivative represented by Chemical Formula 1, which is the object of the present invention.

이상에서 설명한 바와 같은 제조방법에 따르면, 상기 화학식 1로 표시되는 피리돈 유도체는 75% 이상의 높은 수율로 용이하게 합성할 수 있다.According to the manufacturing method as described above, the pyridone derivative represented by the formula (1) can be easily synthesized in a high yield of 75% or more.

이와 같은 본 발명을 다음의 실시예에 의거하여 더욱 상세히 설명하면 다음과 같은 바, 본 발명이 이에 한정되는 것은 아니다.When the present invention is described in more detail based on the following examples, the present invention is not limited thereto.

실시예 1: 1',5',7',8'-테트라하이드로-스파이로[1,3-다이옥소레인-2,6'(2'H)-퀴놀린]-2'온의 제조Example 1: Preparation of 1 ', 5', 7 ', 8'-tetrahydro-spiro [1,3-dioxolane-2,6' (2'H) -quinolin] -2'one

1,4-사이클로헥세인다이온 모노에틸렌 케탈(5.0 g, 32 mmol)을 벤젠(100 mL)에 녹이고 피롤리딘(5.4 g, 64 mmol)과p-톨루엔 술폰산(200 mg, 1.1 mmol)을 가하고 딘-스탁(Dean-Stark) 물 분리기에서 더 이상 물이 나오지 않을 때까지 가열하였다. 벤젠을 진공하에서 제거하고 잔류물을 다이옥산(80 mL)에서 녹인 다음 프로피올 아마이드(6.62 g, 96 mmol) 가하고 다시 10 시간동안 환류하였다. 이나민의 완전한 가수분해를 위해 물(20 mL)를 가하고 10 시간 환류한 후 실온으로 냉각 후 다이옥산을 제거하고 얻은 불순한 잔류물에 물을 가하고 연속추출기를 사용하여 다이클로로메탄으로 추출 후 감압 농축하여 얻은 불순물을 후레쉬 칼럼 크로마토그래피(실리카젤, 10% 메탄올/디클로로메탄)로 분리하여 상기 화학식 1로 표시되는 순수한 피리돈 유도체(4.97 g, 75% 수율)를 얻었다.Dissolve 1,4-cyclohexanedione monoethylene ketal (5.0 g, 32 mmol) in benzene (100 mL), and pyrrolidine (5.4 g, 64 mmol) and p -toluene sulfonic acid (200 mg, 1.1 mmol). It was added and heated until no more water emerged from the Dean-Stark water separator. Benzene was removed in vacuo and the residue was taken up in dioxane (80 mL), then propionol amide (6.62 g, 96 mmol) was added and refluxed again for 10 h. For complete hydrolysis of inamin, water (20 mL) was added, refluxed for 10 hours, cooled to room temperature, dioxane was removed, water was added to the resulting impure residue, extracted with dichloromethane using a continuous extractor, and concentrated under reduced pressure. Impurities were separated by flash column chromatography (silica gel, 10% methanol / dichloromethane) to obtain pure pyridone derivatives represented by Formula 1 (4.97 g, 75% yield).

1H NMR(CDCl3, 200 MHz) δ 12.6(s, brs, 1H), 7.14(d,J=9.3Hz, 1H), 6,40(d,J=9.2Hz, 1H), 4.02(s, 4H), 2.89(t,J=6.5Hz, 2H), 2.71(s, 2H), 1.93(t,J=6.5Hz, 2H). 1 H NMR (CDCl 3 , 200 MHz) δ 12.6 (s, brs, 1H), 7.14 (d, J = 9.3 Hz, 1H), 6,40 (d, J = 9.2 Hz, 1H), 4.02 (s, 4H), 2.89 (t, J = 6.5 Hz, 2H), 2.71 (s, 2H), 1.93 (t, J = 6.5 Hz, 2H).

실시예 2:1',5',7',8'-테트라하이드로-스파이로[5,5-다이메틸1,3-다이옥소레인-2,6'(2'H)-퀴놀린]-2'온의 제조 Example 2 1 ', 5', 7 ', 8'-tetrahydro-spiro [5,5-dimethyl1,3-dioxolane-2,6'(2'H) -quinoline] -2 'Manufacture of the came

1,4-사이클로헥세인다이온 모노-2,2-다이메틸트라이메틸렌 케탈(500 mg, 2.52 mmol)을 벤젠(15 mL)에 녹이고 피롤리딘(358 mg, 5.04 mmol)과p-톨루엔 술폰산(15 mg, 0.08 mmol)을 가하고 딘-스탁(Dean-Stark) 물 분리기에서 더 이상 물이 나오지 않을 때까지 가열하였다. 벤젠을 진공하에서 제거하고 잔류물을 다이옥산(15 mL)에서 녹인 다음 프로피올 아마이드(522 g, 7.56 mmol) 가하고 다시 10 시간동안 환류하였다. 이나민의 완전한 가수분해를 위해 물(2 mL)를 가하고 10 시간 환류한 후 실온으로 냉각 후 다이옥산을 제거하고 얻은 불순한 잔류물에 물을 가하고 다이클로로메탄으로 추출 후 감압 농축하여 얻은 불순물을 후레쉬 칼럼 크로마토그래피(실리카젤, 에틸아세테이트)로 분리하여 상기 화학식 1로 표시되는 순수한 피리돈 유도체(326 mg, 52% 수율)를 얻었다.Dissolve 1,4-cyclohexanedione mono-2,2-dimethyltrimethylene ketal (500 mg, 2.52 mmol) in benzene (15 mL), pyrrolidine (358 mg, 5.04 mmol) and p -toluene sulfonic acid (15 mg, 0.08 mmol) was added and heated until no more water came out of the Dean-Stark water separator. Benzene was removed in vacuo and the residue was taken up in dioxane (15 mL), then propionol amide (522 g, 7.56 mmol) was added and refluxed again for 10 h. For complete hydrolysis of inamin, water (2 mL) was added, refluxed for 10 hours, cooled to room temperature, dioxane was removed, water was added to the resulting impure residue, extracted with dichloromethane, and concentrated under reduced pressure. Separation was performed by chromatography (silica gel, ethyl acetate) to obtain a pure pyridone derivative (326 mg, 52% yield) represented by Chemical Formula 1.

1H NMR(CDCl3, 200 MHz) δ 12.9(brs, 1H), 7.18(d,J=11.8Hz, 1H), 6.39(d,J=11.8Hz, 1H), 3.53(d,J=11.2Hz, 2H), 3.47(d,J=11.3Hz, 2H), 2.79(s, 4H), 2.13(t,J=6.6 Hz, 2H), 1.07, 0.92(2s, 6H). 1 H NMR (CDCl 3 , 200 MHz) δ 12.9 (brs, 1H), 7.18 (d, J = 11.8 Hz, 1H), 6.39 (d, J = 11.8 Hz, 1H), 3.53 (d, J = 11.2 Hz , 2H), 3.47 (d, J = 11.3 Hz, 2H), 2.79 (s, 4H), 2.13 (t, J = 6.6 Hz, 2H), 1.07, 0.92 (2s, 6H).

실시예 3:1',5',7',8'-테트라하이드로-스파이로[5,5-다이메틸1,3-다이옥소레인-2,6'(2'H)-퀴놀린]-2'온의 제조Example 3: 1 ', 5', 7 ', 8'-tetrahydro-spiro [5,5-dimethyl1,3-dioxolane-2,6' (2'H) -quinoline] -2 'Manufacture of the came

1,4-사이클로헥세인 모노-2,2-다이메틸트라이메틸렌 케탈(500 mg, 2.52 mmol)을 벤젠(15 mL)에 녹이고 모르폴린(439 mg, 5.04 mmol)과p-톨루엔 술폰산(15 mg, 0.08 mmol)을 가하고 딘-스탁(Dean-Stark) 물 분리기에서 더 이상 물이 나오지 않을 때까지 가열하였다. 벤젠을 진공하에서 제거하고 잔류물을 다이옥산(15 mL)에서 녹인 다음 프로피올 아마이드(522 g, 7.56 mmol) 가하고 다시 10 시간동안 환류하였다. 이나민의 완전한 가수분해를 위해 물(2 mL)를 가하고 10 시간 환류한 후 실온으로 냉각 후 다이옥산을 제거하고 얻은 불순한 잔류물에 물을 가하고 다이클로로메탄으로 추출 후 감압 농축하여 얻은 불순물을 후레쉬 칼럼 크로마토그래피(실리카젤, 에틸아세테이트)로 분리하여 상기 화학식 1로 표시되는 순수한 피리돈 유도체(270 mg, 43% 수율)를 얻었다.1,4-cyclohexane mono-2,2-dimethyltrimethylene ketal (500 mg, 2.52 mmol) was dissolved in benzene (15 mL), morpholine (439 mg, 5.04 mmol) and p -toluene sulfonic acid (15 mg). , 0.08 mmol) was added and heated until no more water emerged in a Dean-Stark water separator. Benzene was removed in vacuo and the residue was taken up in dioxane (15 mL), then propionol amide (522 g, 7.56 mmol) was added and refluxed again for 10 h. For complete hydrolysis of inamin, water (2 mL) was added, refluxed for 10 hours, cooled to room temperature, dioxane was removed, water was added to the resulting impure residue, extracted with dichloromethane, and concentrated under reduced pressure. Separation by chromatography (silica gel, ethyl acetate) to obtain a pure pyridone derivative (270 mg, 43% yield) represented by the formula (1).

이상에서 설명한 바와 같이, 본 발명에 따른 제조방법은 고압반응기를 사용하거나 또는 복잡한 반응 공정을 수행하지 않고서도 목적하는 피리돈 유도체를 고수율로 수득할 수 있으므로 공업적으로 매우 유용하다.As described above, the production method according to the present invention is very industrially useful because the desired pyridone derivative can be obtained in high yield without using a high pressure reactor or performing a complicated reaction process.

Claims (3)

다음 화학식 2로 표시되는 1,4-사이클로헥세인다이온 모노케탈을 2차아민과 산 촉매하에 반응시킨 후에, 다음 화학식 3으로 표시되는 프로피올아미드로 처리하여 제조하는 것을 특징으로 하는 다음 화학식 1로 표시되는 피리돈 유도체의 제조방법.The following Chemical Formula 1 is prepared by reacting a 1,4-cyclohexanedione monoketal represented by the following Chemical Formula 2 with a secondary amine under an acid catalyst, and then treating it with propiolamide represented by the following Chemical Formula 3. Method for producing a pyridone derivative represented by. 화학식 2Formula 2 화학식 3Formula 3 화학식 1Formula 1 상기 화학식에서 : R1및 R2는 각각 C1∼C6알킬기이거나, 또는 R1및 R2가 서로 결합하여 5원자 내지 8원자 헤테로 고리를 형성할 수 있다.In the above formula: R 1 and R 2 are each a C 1 ~ C 6 alkyl group, or R 1 and R 2 may be bonded to each other to form a 5 to 8 membered hetero ring. 제 1 항에 있어서, 상기 2차아민이 피롤리딘, 모르폴린 및 피페리딘 중에서 선택된 이나민류인 것을 특징으로 하는 제조방법.The method according to claim 1, wherein the secondary amine is an inamine selected from pyrrolidine, morpholine, and piperidine. 제 1 항에 있어서, 상기 산촉매가 p-톨루엔술폰산, 캄파술폰산, 피리디니움 파라톨루엔술폰산 및 황산 중에서 선택된 것을 특징으로 하는 제조방법.The method of claim 1, wherein the acid catalyst is selected from p-toluenesulfonic acid, campasulfonic acid, pyridinium paratoluenesulfonic acid, and sulfuric acid.
KR10-2000-0078674A 2000-12-19 2000-12-19 A process for preparing pyridone derivative KR100390777B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2000-0078674A KR100390777B1 (en) 2000-12-19 2000-12-19 A process for preparing pyridone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0078674A KR100390777B1 (en) 2000-12-19 2000-12-19 A process for preparing pyridone derivative

Publications (2)

Publication Number Publication Date
KR20020049492A true KR20020049492A (en) 2002-06-26
KR100390777B1 KR100390777B1 (en) 2003-07-10

Family

ID=27683453

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2000-0078674A KR100390777B1 (en) 2000-12-19 2000-12-19 A process for preparing pyridone derivative

Country Status (1)

Country Link
KR (1) KR100390777B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106979A (en) * 1989-02-21 1992-04-21 University Of Pittsburgh Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
US4929731A (en) * 1989-02-21 1990-05-29 University Of Pittsburgh Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
CN1125725A (en) * 1994-12-28 1996-07-03 中国科学院上海药物研究所 First-kind "Haikelin" alkali derivant and its usage
AU8925998A (en) * 1997-09-03 1999-03-22 Macro Hi-Tech Jv, Ltd. Huperzine a derivatives

Also Published As

Publication number Publication date
KR100390777B1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
JP7398436B2 (en) Methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7 ] Annelene-2-carboxylate salt and method for producing the same
US5965734A (en) Processes and intermediates for preparing 2-substituted piperidine stereoisomers
JP2009502750A (en) Nebivolol manufacturing method
KR100390777B1 (en) A process for preparing pyridone derivative
JP2000026418A (en) New production of derivative of 4-phenyl-1,2,3,6- tetrahydropyridine and intermediate used therefor
KR100374767B1 (en) Improved method of preparing amlodipine
KR100743617B1 (en) Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity
JP2001521498A (en) Method for producing O- (3-amino-2-hydroxy-propyl) -hydroxymic acid halide
KR101686087B1 (en) Process for Production of Optically Active Indoline Derivatives or Salts Thereof
JP4057088B2 (en) Method for producing pyrrolidine derivative
CN114805168B (en) Pyrrolinones and synthesis method thereof
KR100879120B1 (en) Method of Preparing Donepezil and Its Intermediate
RU2155752C2 (en) Methods for preparation of 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives in the form of r isomers and their salts, starting substances and intermediates for preparation thereof
KR100354806B1 (en) New intermediate for the preparation of amlodipine besylate and its process
KR100297802B1 (en) Method for preparing 2- (3-trifluoromethyl) anilinonicotinic acid 2- (N-morpholine) ethyl.
KR900007314B1 (en) Process for preparing n-(methoxyacetyl)-n-(2,l-dimethyl phenyl)-o-amino-oxazolidine-2-one
CN117486810A (en) Synthesis method of 2, 5-disubstituted piperazine derivative
CN113979977A (en) Hexa-membered oxygen heterocyclic compound and synthetic method thereof
JP2000515534A (en) Method for producing 3,3-disubstituted piperidine
JPH0559045A (en) Production of pyridyloxy derivative
JPS6341907B2 (en)
JP2703048B2 (en) Production method of proline derivative
JP4507390B2 (en) 1-alkyl-1-substituted-3-organosulfonyloxyazetidinium salts and process for producing the same
CN116396272A (en) Preparation method of 2, 5-dihydropyrrolidine derivative and racemic nicotine
JP4441260B2 (en) Process for producing 4-amino-4-phenylpiperidines

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20080530

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee